Oncology Institute Stock Analysis

Oncology Stock Analysis Notes

About 35.0% of the company shares are owned by institutional investors. The company has Price/Earnings (P/E) ratio of 190.67. Oncology Institute recorded a loss per share of 0.7. The entity had not issued any dividends in recent years. The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California. Oncology Institute operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 658 people. To find out more about Oncology Institute contact Bradford Hively at 562 735 3226 or learn more at https://theoncologyinstitute.com.

Oncology Institute Investment Alerts

Oncology Institute Upcoming and Recent Events

Oncology Largest EPS Surprises

View All Earnings Estimates

Oncology Institute Environmental, Social, and Governance (ESG) Scores

Oncology Institute Thematic Classifications

Oncology Stock Institutional Investors

Note, although Oncology Institute's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Oncology Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 325.37 M.

Oncology Profitablity

The company has Net Profit Margin of (0.16) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.09) %, which entails that for every $100 of revenue, it lost $0.09.

Management Efficiency

Oncology Institute has Return on Asset of (0.1766) % which means that on every $100 spent on assets, it lost $0.1766. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (2.7762) %, meaning that it generated no profit with money invested by stockholders. Oncology Institute's management efficiency ratios could be used to measure how well Oncology Institute manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.45. The current Return On Capital Employed is estimated to decrease to -0.52. As of now, Oncology Institute's Other Current Assets are increasing as compared to previous years. The Oncology Institute's current Debt To Assets is estimated to increase to 0.75, while Non Currrent Assets Other are projected to decrease to under 377.6 K.

Technical Drivers

As of the 23rd of July, Oncology Institute holds the Risk Adjusted Performance of 0.1484, semi deviation of 5.94, and Coefficient Of Variation of 646.71. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oncology Institute, as well as the relationship between them.

Oncology Institute Price Movement Analysis

Oncology Institute Insider Trading Activities

Oncology Institute Outstanding Bonds

Oncology Institute Predictive Daily Indicators

Oncology Institute Forecast Models

Oncology Institute's time-series forecasting models are one of many Oncology Institute's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Oncology Institute's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Oncology Institute prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Oncology shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Oncology Institute. By using and applying Oncology Stock analysis, traders can create a robust methodology for identifying Oncology entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Oncology analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Oncology analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Oncology Institute stock analysis indicators help investors evaluate how Oncology Institute stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Oncology Institute shares will generate the highest return on investment. By understating and applying Oncology Institute stock analysis, traders can identify Oncology Institute position entry and exit signals to maximize returns.

When running Oncology Institute's price analysis, check to measure Oncology Institute's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncology Institute is operating at the current time. Most of Oncology Institute's value examination focuses on studying past and present price action to predict the probability of Oncology Institute's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncology Institute's price. Additionally, you may evaluate how the addition of Oncology Institute to your portfolios can decrease your overall portfolio volatility.